Private Trust Company’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.59K Sell
293
-21
-7% -$756 ﹤0.01% 2099
2026
Q1
$11.1K Hold
314
﹤0.01% 1938
2025
Q4
$12.7K Buy
314
+311
+10,367% +$13.5K ﹤0.01% 1850
2025
Q3
$141 Buy
+3
New +$156 ﹤0.01% 2531

Other funds holding CNMD

Private Trust Company's CNMD Position: Q2 2026 in Review

Private Trust Company reduced its CONMED (CNMD) stake by 6.7% in Q2 2026, selling an estimated $756 and leaving 293 shares worth $9.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Private Trust Company first reported a position in CNMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $12.7K in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Private Trust Company held 293 shares of CONMED worth $9.59K as of Q2 2026.
  • Private Trust Company sold 21 CONMED shares in Q2 2026, an estimated $756.
  • CONMED made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2099 holding.
  • Private Trust Company first reported a position in CONMED in Q3 2025 and has held it in 4 quarters since.
  • Private Trust Company's CONMED position peaked at $12.7K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.